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Multisite phosphorylation of c-Jun at threonine 91/93/95
triggers the onset of c-Jun pro-apoptotic activity
in cerebellar granule neurons
CE Reddy1, L Albanito1,4, P De Marco2, D Aiello3, M Maggiolini2, A Napoli3 and AM Musti*,1,2
Cerebellar granule cell (CGC) apoptosis by trophic/potassium (TK) deprivation is a model of election to study the interplay of
pro-apoptotic and pro-survival signaling pathways in neuronal cell death. In this model, the c-Jun N-terminal kinase (JNK)
induces pro-apoptotic genes through the c-Jun/activator protein 1 (AP-1) transcription factor. On the other side, a survival
pathway initiated by lithium leads to repression of pro-apoptotic c-Jun/AP-1 target genes without interfering with JNK activity.
Yet, the mechanism by which lithium inhibits c-Jun activity remains to be elucidated. Here, we used this model system to study
the regulation and function of site-specific c-Jun phosphorylation at the S63 and T91/T93 JNK sites in neuronal cell death.
We found that TK-deprivation led to c-Jun multiphosphorylation at all three JNK sites. However, immunofluorescence analysis of
c-Jun phosphorylation at single cell level revealed that the S63 site was phosphorylated in all c-Jun-expressing cells, whereas
the response of T91/T93 phosphorylation was more sensitive, mirroring the switch-like apoptotic response of CGCs. Conversely,
lithium prevented T91T93 phosphorylation and cell death without affecting the S63 site, suggesting that T91T93 phosphorylation
triggers c-Jun pro-apoptotic activity. Accordingly, a c-Jun mutant lacking the T95 priming site for T91/93 phosphorylation
protected CGCs from apoptosis, whereas it was able to induce neurite outgrowth in PC12 cells. Vice versa, a c-Jun mutant
bearing aspartate substitution of T95 overwhelmed lithium-mediate protection of CGCs from TK-deprivation, validating that
inhibition of T91/T93/T95 phosphorylation underlies the effect of lithium on cell death. Mass spectrometry analysis confirmed
multiphosphorylation of c-Jun at T91/T93/T95 in cells. Moreover, JNK phosphorylated recombinant c-Jun at T91/T93 in a
T95-dependent manner. On the basis of our results, we propose that T91/T93/T95 multiphosphorylation of c-Jun functions as a
sensitivity amplifier of the JNK cascade, setting the threshold for c-Jun pro-apoptotic activity in neuronal cells.
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By forming stable homodimer or heterodimer complexes with
Fos or ATF family members, c-Jun constitutes the inducible
activator protein 1 (AP-1) transcription factor.1,2 Genetic
studies have demonstrated a crucial role for c-Jun/AP-1 in
different cellular programs, as cell cycle progression, differ-
entiation and apoptosis.3,4 c-Jun transactivation is mainly
regulated by the c-Jun N-terminal kinase (JNK) pathway,
through phosphorylation of its N-terminal domain at S63/S73
and threonine T91/T93.5–9 These two groups of phosphoryla-
tion regulate c-Jun transactivity by two distinct mechanisms.
In the first mechanism, S63/S73 phosphorylation promotes
the expression of c-Jun target genes by facilitating c-Jun
physical interactions with the coactivator CPB/p300.10,11 In
the second mechanism, c-Jun phosphorylation on both
S63/S73 and T91/T93 is necessary for releasing specific
c-Jun target genes from transcriptional repression.7,12,13
These studies suggest that, whereas S63/S73 phosphoryla-
tion is necessary for both mechanisms of c-Jun transactiva-
tion, T91/T93 phosphorylation may act as a regulatory signal
switching ‘on’ specific classes of c-Jun/Ap-1 target genes by
transcriptional derepression. In line with this hypothesis,
S63/S73 phosphorylation is induced by a myriad of extra-
cellular signals with either transient or prolonged signaling
dynamics14,15 and it functions in diverse physiological path-
ways, inducing genes involved in cell cycle progression,
differentiation and apoptosis.3,4,16 Differently, T91/T93 phos-
phorylation by JNK is induced mostly by destructive cues,
including genotoxic stress and chemotherapeutic drugs.8,14,17
Moreover, T91/T93 phosphorylation requires a priming event
at the adjacent T95 site.8 Abrogation of this priming site
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impairs c-Jun transactivation and lead to selective inhibition of
T91/T93 phosphorylation by various types of genotoxic
stress, including UV radiation and anisomycin.8 Importantly,
it has been shown that in mammal cells the JNK cascade
converts damaging stress stimuli in a sensitive switch-like
response.18 Therefore, the differential regulation of the
S63/S73 sites versus the T91/T93 may reflect a switch-like
response of JNK to genotoxic cues, with small stimuli rising
S63/S73 phosphorylation and larger supra-threshold stimuli
inducing T91/T93 phosphorylation.
In the central nervous system, c-Jun transactivation by JNK
has a crucial role in diverse cellular processes, including
neuronal cell death, glial-mediated neuroinflammation and
neurite outgrowth.19–21 Until now, the relevance of c-Jun
N-terminal phosphorylation in these processes has been
examined only for the S63/S73 sites.22–24 These studies have
shown that S63/S73 phosphorylation is crucial for exitotoxic
neuronal apoptosis22 and for neuronal cell death by either
trophic or tropic/potassium deprivation of sympathetic
neurons and cerebellar granule cells (CGC), respectively.23,25
However, S63/S73 phosphorylation is also involved in
neuronal differentiation processes, as neurite outgrowth in
PC12 cells26,27 and neurotransmitter specification in early
neuronal development.28 Moreover, S63/S73 phosphoryla-
tion is required for the induction of inflammatory cytokines in
immune-regulatory cells, including spinal astrocytes and
Bergman glial cells.20,29,30 Yet, an important question remains
as how can the JNK signaling pathway act through the same
transcription factor to evoke quite different cellular responses.
Here, we have investigated the function of site-specific
regulation of c-Jun multiphosphorylation at the S63 and
T91/T93 JNK sites in CGC apoptosis by trophic/potassium
(TK)-deprivation. This model of cell death is dependent on
c-Jun expression and transactivation by JNK, which in turn
leads to the induction of pro-apoptotic genes, such as Puma
(p53 upregulated modulator of apoptosis) and Bim (Bcl2-inter-
acting mediator of cell death).24 Conversely, CGC apoptosis
by TK-deprivation is impaired by lithium, through a survival
pathway involving glycogen synthase kinase 3 beta (GSK3b)
inhibition and the repression of pro-apoptotic c-Jun target
genes, without interfering with JNK activity.31,32 We provide
evidence that lithium protects CGCs from TK-deprivation by
inhibiting c-Jun phosphorylation at T91/T93/T95 sites.
Furthermore, we show that abrogation of T91/T93/T95
phosphorylation has no consequence on the capacity of
c-Jun to induce neurite outgrowth in PC12 cells, suggesting
that site-specific regulation of c-Jun phosphorylation is one
possible mechanism underlying the functional dichotomy of
the JNK/c-Jun pathway in the brain.
Results
Phosphorylation of c-Jun N-terminal domain in
cerebellar granule neurons. To investigate the role of
c-Jun phosphorylation at T91/T93 in neuronal death, we set
up a previously described experimental system consisting of
primary cultures of mouse CGCs undergoing cell death in
response to TK-deprivation.24 P7 mouse cerebella were
used to generate CGCs, which were cultured for 7 days
(DV7) in presence of serum and high potassium concentra-
tion (25 mM); CGC culture were then switched to low
potassium concentration (5 mM) for further 18 h. Cell death
of CGCs was assessed at single cell level by examining the
nuclear morphology of DAPI-stained nuclei using immuno-
fluorescence microscopy. It is worth noting that in our
experimental settings (see Supplementary Figure 1) 100%
of DAPI-stained condensed nuclei resulted terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (TUNEL)-
positive, confirming that morphological analysis of
DAPI-stained nuclei is a valuable assay to detect apoptosis.
In line with previous studies31,32 we found thatB55% of cells
presented condensed nuclei in TK-deprived CGC cultures,
whereas the JNK-specific inhibitor SP100125 (SP) and
lithium reduced the frequency of condensed nuclei to 8%
and 18%, respectively (Figure 1a).
Next, we investigated site-specific c-Jun N-terminal phos-
phorylation by TK-deprivation, using site-specific c-Jun
antibodies recognizing c-Jun when phosphorylated at S63
(c-Jun-p63) or at T91/T93 (c-Jun-p91/93). c-Jun phospho-
rylation was evaluated at 4 h after TK-deprivation, as maximal
c-Jun phosphorylation by TK was reported to arise at this time
period.33 We found that TK-deprivation induced c-Jun protein
levels and c-Jun phosphorylation at both S63 and T91/T93
in a SP-sensitive manner (Figure 1b and c). This finding is in
agreement with previous studies demonstrating that both
c-Jun expression and N-terminal phosphorylation are depen-
dent on JNK activity.1,4,14 In contrast, lithium significantly
impaired T91/T93 phosphorylation, whereas had no effects on
S63 phosphorylation or JNK activation.
The pattern of S63 and T91/93 phosphorylation was then
confirmed at single cell level. To this aim, we used site-specific
c-Jun phospho-antibodies or total c-Jun antibodies to perform
immunofluorescence analysis of c-Jun phosphorylation after
4 h of TK-deprivation (Figure 1d–f). In addition, parallel CGC
Figure 1 c-Jun N-terminal phosphorylation in cerebellar granule neurons. (a) CGCs were cultured in 25 mM K and then switched to 5 mM K medium for 18 h, either in
absence or in presence 10mM SP600125 (SP) or 10mM LiCl, as indicated. Cells were then fixed and nuclei were stained with DAPI. Condensed nuclei were counted by
fluorescence microscopy. Columns indicate the average percentage number of condensed nuclei present in 10 different fields, with bars indicating S.D. (b) Western blot
analysis of CGCs cultured either in 25 or 5 mM K medium for 4 h and treated with either SP600125 (10mM) or LiCl (10 mM) as indicated. c-Jun N-terminal phosphorylation or
phosphorylated JNK (p-JNK) were determined by using the indicated antibodies. c-Jun expression levels were measured by using a total c-Jun antibody as indicated. Protein
levels were normalized by using the Mcm7 antibody. (c) Densitometric analysis of western blot analysis shown in panel c. Values are presented as optical density
(OD; expressed in arbitrary units) relative to the control (Mcm7). Bars represent S.D. from three different densitometric quantification of analogous experiments shown in panel
c. (d–f) Immunofluorescence analysis of CGCs cultured in 25 or 5 mM K medium for 4 h and treated with either SP600125 (10 mM) or LiCl (10mM) as indicated. Cells were
then fixed and nuclei were stained with DAPI; c-Jun N-terminal phosphorylation and expression were detected by immunocytochemical staining using c-Jun-p63 Ab (d), or
c-Jun-pT-91/T93 (e), or c-Jun total Ab (f). (g) Immunofluorescence analysis of CGC cultures TK-deprived for 18 h and analyzed for condensed nuclei by DAPI staining.
(h) Quantification of results shown in d–g. Columns indicate the average percentage number of immunoreactive cells (d–f) or condensed nuclei (g) present in 10 different
fields, with bars indicating S.D.
Regulation of c-Jun multisite phosphorylation
CE Reddy et al
2
Cell Death and Disease
cultures were TK-deprived for 18 h and analyzed for
condensed nuclei by DAPI staining (Figure 1g). As shown in
Figure 1d–h, the percentage of TK-deprived cells resulting
positive for either total c-Jun or c-Jun-p63 antibodies were
very comparable, indicating that c-Jun was phosphorylated at
S63 in the vast majority of c-Jun-expressing cells (70% of total
cells). On the other hand, the percentage of cells positive for
c-Jun-p91/93 was circa 55% of total TK-deprived cells,
indicating that extensive N-terminal phosphorylation at
both S63 and T91/T93 is present only in a subpopulation of
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c-Jun-expressing cells. This finding suggests that TK-depri-
vation differentially regulates S63 and T91/T93 phosphoryla-
tion of c-Jun, with the T91/T93 sites responding in a sensitive
fashion and mirroring the switch-like apoptotic response of
TK-treated CGCs (compare the percentage of apoptotic cells
with that of T91/T93-positive cells).
Lack of T91/93 phosphorylation impairs apoptosis but
not neurite outgrowth. As c-Jun phosphorylation at
T91–93 is dependent on the T95 priming site,8 we then
validated the role of the T91/T93 sites in neuronal cell death.
To this aim, we analyzed a c-Jun mutant bearing alanine
substitution of T95 (c-JunA95). We used a lentiviral approach
to reintroduce the expression of either influenza-hemagglu-
tinin (HA)-tagged c-Jun-wt or c-JunA95 proteins in primary
CGCs cultures generated from conditional KO mice lacking
c-Jun expression in the CNS (c-Jun DN mice).34 As the
percentage of lentiviral-infected cells was circa 70% of total
cells, we used the non-infected cells as internal control.
As expected from previous studies, we found that the rate of
TK-induced apoptosis resulted reduced in CGCs generated
from JunDN mice (19 versus 60% of c-Jun-expressing
CGCs) (Figure 2c). In contrast, TK-deprivation efficiently
induced cell death in CGCs expressing c-Jun-wt proteins. In
contrast, cell death was impaired in CGCs expressing the
c-JunA95 mutant. These results indicate that reintroduction
of c-Jun-wt expression, but not that of the c-JunA95 mutant,
restores the standard rate of CGC apoptosis by TK-
deprivation in c-JunDN mice. Notably, c-Jun-wt was fully
phosphorylated at both S63 and T91/T93 in response to TK-
deprivation, whereas N-terminal phosphorylation of
c-JunA95 was restricted to S63 (Figure 2d), confirming the
crucial role of the T95 site in priming T91/T93 phosphoryla-
tion by TK-deprivation.
As c-Jun is a transcriptional factor, we next evaluated
whether the inability of the c-JunA95-HA mutant to rescue
apoptosis was coupled to the lack of c-Jun transactivity.
To this aim, we performed reporter gene assays using a
Figure 2 Lack of T91/93 phosphorylation protects from cell death. (a and b) Confocal analysis of CGCs generated from c-Jun-DN mice and infected with GFP-tagged
lentivirus particles expressing either HA-tagged c-Jun proteins: c-Jun-wt-HA (a) or c-JunA95-HA (b). After infections, cells were cultured for 6 days and then treated as
indicated for 18 h. After fixation, nuclei were stained by DAPI and immunostained with HA antibody. (c) Quantification of results shown in a and b. Columns indicate the
average percentage number of condensed nuclei present in 10 different fields, with bars indicating S.D. (d) Western blot analysis of CGCs from c-Jun-DN mice infected with
lentivirus as described in a and b. After infection, cells were cultured either in 25 mM K or shifted to 5 mM K medium for 4 h, as indicated. Control represents not infected CGCs.
c-Jun N-terminal phosphorylation was determined by using the indicated c-Jun phospho-specific antibodies. The levels of c-Jun-HA proteins were determined by using the HA
antibody. (e) CGCs from c-Jun-DN mice were transfected with Jun2-luc reporter plasmids in combination with plasmids expressing either c-Jun-wt-HA or c-JunA95-HA
proteins or empty vector (indicated as control). After infection, cells were cultured either in 25 mM K or shifted to 5 mM K medium for 4 h, as indicated. The luciferase activities
were normalized to the internal transfection control. Values of CGCs transfected with empty vectors and cultured in 25 mM K were set as onefold induction. Bar graphs
represent the mean±S.D. of three independent assays
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Jun2-luciferase (Jun2-luc) reporter, previously shown to be
induced by TK-deprivation in CGCs.25 The Jun2-luc reporter
was transfected in CGCs generated from c-JunDN mice,
either alone or together with expression vectors expressing
either c-Jun-wt-HA or c-JunA95-HA proteins. As expected,
the c-Jun2-luc reporter was not induced by TK-deprivation in
CGCs from c-JunDN mice. Conversely, reintroduction of
c-Jun-wt-HA caused approximately a threefold increase of
luciferase activity in response to TK-deprivation, whereas
c-JunA95-HA had a very limited effect. Notably, the western
analysis shown in Figure 2d indicates that c-Jun-wt-HA and
c-JunA95-HA proteins have equal steady-state expression
levels in CGCs. Taken together, these results suggest that
lack of c-Jun phosphorylation at the T91/T93/T95 sites
impairs the induction of c-Jun transactivity by TK-deprivation
and in turn protects from cell death.
Next, we investigated the capability of the c-JunA95 mutant
to induce neurite outgrowth in PC12 cells cultured in absence
of nerve growth factor (NGF), a well described process that is
induced by ectopic expression of c-Jun and depend on
S63/S73 phosphorylation26,27 As shown in Figure 3, c-Jun-wt
and c-JunA95 were equally able to induce neurite outgrowth in
naı¨ve PC12 cells. These results exclude that the effect of the
c-JunA95 mutant on cell death was secondary to a defect
altering c-Jun transactivity independently of T91/T93 phos-
phorylation. In addition, they establish that c-Jun multipho-
sphorylation on T91/T93/T95 is required for neuronal cell
death of CGCs, whereas it has no roles in Jun-dependent
neurite outgrowth in naı¨ve PC12 cells.
Deregulation of c-Jun phosphorylation at the T91/T93
sites recovers apoptosis in presence of lithium. Next, we
assessed whether lithium protect CGCs from TK-deprivation
by inhibiting the priming event preceding T91/T93 phospho-
rylation. To assess this hypothesis, we used a c-Jun mutant
bearing aspartate substitution of T95 (c-JunD95), which was
previously shown to acquire the same kinetic of S63/S73
phosphorylation in response to JNK activation.8
As shown in Figure 4, we found that lithium impaired
TK-deprivation-induced apoptosis in CGCs generated
from c-JunDN mice and expressing c-Jun-wt proteins
(Figure 4a), whereas it had a poor protective effect in
GCGs expressing c-JunD95-mutated proteins (Figure 4b).
However, the JNK inhibitor SP100125 efficiently inhibited
TK-induced apoptosis in both circumstances, excluding that
the c-JunD95 mutant acts independently from JNK transacti-
vation (Figure 4a–c). These results suggest that inhibition of
T91/93/95 phosphorylation underlies the effect of lithium on
cell death.
The T95 site of c-Jun is phosphorylated in vivo. Our
results suggest that lithium controls c-Jun pro-apoptotic
activity by regulating the priming event preceding T91/93
phosphorylation. Most probably, this priming event consists
in phosphorylation of the T95 sites, as suggested by the
finding that the c-JunD95 overcomes the effect of lithium on
cell death. To exclude that a different post-translational
modification of T95 primes T91/93 phosphorylation, we
validated that T95 is phosphorylated in cells. To this aim,
we used mass spectrometry methodologies35,36 to identify
N-terminal phosphopeptides of c-Jun proteins ectopically
expressed in HEK-T 293 cells. First, we performed analytical
experiments to analyze c-Jun phosphorylation in HEK-T 293
cells. HEK-T 293 cells were transfected with a vector
expressing human c-Jun and then treated with anisomycin,
a strong activator of JNKs. c-Jun resulted fully phosphory-
lated on both S63 and T91/T93, either before or after
anisomycin treatments (Figure 5a), owing to the constitutive
activation of JNKs in this cell line.37 However, c-Jun
phosphorylation at T91/T93 was dependent on the priming
event at T95, as the c-JunA95 mutant resulted phosphory-
lated only at the S63 site (Figure 5b). Next, c-Jun-wt proteins
were immunoprecipitated from transfected cells and
immunocomplexes were processed for MALDI MS and
MS/MS. In parallel, immunocomplexes were analyzed by
western analysis to confirm the presence of phosphorylated
T91/T93 residues (Figure 5b).
Following in-gel digestion of c-Jun immunocomplexes with
proteinase K (PK), the fraction of phosphopeptides was
enriched by hydroxyapatite affinity chromatography (HAP)
and analyzed by MALDI MS and MS/MS. All identified
phosphopeptides are listed in Table 1. In-gel PK digestion of
c-Jun immunocomplexes generated three major multi-
phosphorylated peptides. In particular, three different three-
phosphopeptides were identified as residues 80–97, 82–97
and 89–98. The CID spectrum of segment 82–97 (m/z
1956.73) is given in Figure 5c. For this segment, the MS/MS
spectrum showed b (b-H3PO4) and y (y-H3PO4) ion series,
allowing the assignment of either peptide sequence and
phosphorylation sites at the T91, T93 and T95 residues. All
the b-series fragments down to b10 (m/z 1107.7) showed the
ability to lose H3PO4 ( 98 Da), whereas the b9 (m/z 926.7)
fragment was present only in a non-phosphorylated state,
indicating that the ninth residue from the N-terminus (T91) is
phosphorylated. In addition, the mass difference between the
b10 (m/z 1107.7) and b9 (m/z 926.7) ions is consistent with the
mass of a phosphothreonine residue (181 Da). Furthermore,
the presence of the ion peak b14-98 (m/z 1566.0) and of the
unmodified counterpart y2 (m/z 294.2) is consistent with a
phosphorylated T95 residue. The presence of T95 phosphor-
ylation is also reliable with the mass difference between the y2
(m/z 294.2) and y3 (m/z 475.1) ions (181 Da). Accordingly,
T93 phosphorylation was assigned by considering the mass
difference between the y5-98 (m/z 655.4) and y4-98
(m/z 474.4) ions, as it was consistent with the mass of a
phosphothreonine residue (181 Da). In a similar fashion, both
phosphopeptides 80–97 and 89–98 resulted to be phosphory-
lated on T91, T93 and T95. A similar set of b (b-H3PO4) and y
(y-H3PO4) ions was observed for both the doubly phosphory-
lated peptide (83–93) of m/z 1473.58, and the mono-
phosphorylated peptide (82–97) of m/z 1796.80, allowing
the assignment of T91–T93 and T91 phosphorylations,
respectively (see Supplementary Figures 2 and 3).
Figure 5d shows the MS/MS spectrum for the precursor ion
of m/z 1144.57 of sequence TpSDVGLLK. Interpretation
of the MS/MS spectrum was straightforward because a
complete b (b-H3PO4) and y ion series was identified, with
the b2-98 fragment indicating that phosphorylation
occurred at the second residue from the N-terminus. This
phosphorylation site was unambiguously assigned to S63.
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Similarly, phosphopeptides 56–69 and 61–68 resulted to be
phosphorylated at S63.
JNK-1 phosphorylates T91/93 residues of recombinant
c-Jun proteins in vitro. Having shown that T95 is phospho-
rylated in vivo, we then asked whether the T95 site could be
directly phosphorylated in vitro by JNK or by the lithium-
sensitive kinase GSK3b To this end, we transfected NSC-34
cells with plasmids expressing either c-Jun-wt-HA
or c-JunA95-HA-tagged proteins and performed in vitro
phosphorylation of immunoprecipitated c-Jun-HA proteins
by using HA antibodies. c-Jun-HA immunocomplexes were
then used as substrates for in vitro phosphorylation assays
by using recombinant JNK-1, either alone or in combination
with recombinant GSK3b. Given that T91/T93 phosphoryla-
tion is strictly dependent on the priming phosphorylation
event at the T95 site, we assumed that the phosphorylation
status of T91/T93 could indirectly monitor the capacity of
either JNK or GSK3b to phosphorylate T95. Therefore,
products of in vitro phosphorylation reactions were analyzed
by western blot using phospho-specific antibodies for either
p-T91/T93 or for p-S63. As western analysis of NSC-34 total
extracts revealed that Jun-HA proteins have quite low basal
phosphorylation levels of the T239 GSK3b site but fairly good
levels of the T243 priming site for T239 phosphorylation
(Figure 6a), we also monitored the phosphorylation status
of the T239 by using a p-T239 phospho-specific antibody.
As shown in the new Figure 6b, recombinant JNK-1 was fully
able to phosphorylate immunoprecipitated c-Jun-wt-HA at
both S63 and T91/93 sites, whereas JNK-1 phosphorylated
immunoprecipitated c-JunA95-Ha proteins only at the S63
site. In contrast, recombinant GSK3b had no effect of either
S63 or T91/93 but it was fully able to phosphorylate both
forms of c-Jun-HA proteins at the T239 site. It is worth to note
that the mobility shift of c-Jun-HA proteins detected by
HA-Ab (in the samples incubated with JNK-1) is due to S63
phosphorylation and therefore is observed in both c-Jun-
wt-Ha and c-Jun-A95-HA proteins.
To rule out that T95 phosphorylation of c-Jun-HA immuno-
complexes was achieved by a c-Jun-interacting kinase
Figure 3 Lack of T91/93 phosphorylation does not impair neurite outgrowth. (a) Confocal analysis of PC12 cells were cultured either in absence or in presence of NFG
(72 h) as indicated. After fixation, cells were immunostained with neurofilament (NLF, green) antibodies. Nuclei were stained with DAPI (b) Naive PC12 cells were transfected
with DNA constructs expressing either HA-tagged c-Jun-wt or Ha-tagged c-JunA95 constructs, as indicated. Transfected cells were cultured in absence of NGF for 72 h; after
fixation cells were incubated with either HA (red) or NLF, green antibodies. (c) Columns indicates the average percentage number of PC12 cells with neurites present in 10
different fields, with bars indicating S.D.
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different from JNK, we then performed in vitro phosphorylation
of FL-c-Jun recombinant protein. As shown in the new
Figure 6c, we found that recombinant JNK-1 was able to
phosphorylate recombinant FL-c-Jun at both the S63 and
T91/93 sites. All together these experiments indicate that
JNK-1 is able to directly phosphorylate c-Jun at the canonical
JNK T91/T93 sites and at the non-canonical T95 site.
However, we cannot exclude that in vivo a lithium-sensitive
kinase, different from GSK3b, is the main kinase phospho-
rylating the priming T95 site.
Discussion
Gene expression by the JNK/c-Jun pathway is involved in very
different cellular programs, including cell cycle progression,
differentiation and apoptosis. In turn, deregulation of the
JNKs/c-Jun pathway may give rise to pathological conditions,
including tumor progression, neuroinflammation and degen-
erative loss of neurons.8,38 The challenging question is how
can the same signaling pathway regulate the expression of
genes involved in quite different cellular programs. One level
of regulation is certainly represented by the type of c-Jun
partner forming the dimeric AP-1 transcription factor, which in
turn binds and transactivates subsets of target genes.1,25
A second level of regulation is generated by the kinetic of the
JNK/c-Jun signaling pathway. Several studies have shown
that depending on the kinetic of JNK activation, variations in
c-Jun levels and activation periods are coupled to different
patterns of gene expression.39–41 Here, we propose that
depending on the complexity of external signals and their
interplay with intrinsic cues, c-Jun multiphosphorylation by
JNK may result differential at a site-specific level and in turn
elicit different physiological responses. In particular, we
provide evidence that in CGCs, apoptotic cues lead to
extensive multiphosphorylation of c-Jun N-terminal domain,
with T91/T93 phosphorylation setting the threshold for c-Jun
pro-apoptotic activity. In contrast, a concomitant activation
of survival pathways initiated by lithium inhibits T91T93
phosphorylation with no effects on S63 phosphorylation,
hence preventing the onset of c-Jun pro-apoptotic activity
without interfering with possible non-destructive functions of
c-Jun requiring S63 phosphorylation.
Two lines of evidence indicate that T91/T93 phosphoryla-
tion results in a threshold for c-Jun pro-apoptotic activity. The
first evidence addresses the type of response of T91/T93
phosphorylation to apoptotic cues and comes from immuno-
fluorescence analysis of c-Jun site-specific phosphorylation.
This analysis shows that the response of T91/T93 phosphory-
lation to TK-deprivation is not graded but rather sensitive and
mirrors the switch-like apoptotic response of TK-deprived
neurons. The second evidence addresses the functional role
of T91/T93 phosphorylation in triggering c-Jun pro-apoptotic
activity and comes from the functional analysis of the
c-JunA95 mutant in CGC apoptosis. This analysis shows
that c-JunA95-mutated proteins are not phosphorylated at
T91/T93 in response to TK-deprivation, are unable
to transactivate a c-Jun/AP-1 reporter gene and failed to
promote CGC apoptosis. These findings confirm that in
absence of T91/T93 phosphorylation, S63-phopshorylated
c-Jun is not able to promote cell death. In addition, they
Figure 4 Deregulation of T91/T93 phosphorylation recovers cell death in presence of lithium. (a and b) Confocal analysis of CGCs generated from c-Jun DN mice and
infected with GFP-tagged lentivirus particles expressing c-Jun-wt-HA (a) or Ha-c-JunD95-HA proteins (b). After transduction, cells were cultured for 6 days and then treated as
indicated with 25 or 5 mM K for 18 h, with or without SP600125 (10 mM) or LiCl (10 mM) as indicated. After fixation, nuclei were stained by DAPI and immunostained with HA
antibody (red). (c) Quantification of results shown in a and b. Columns indicate the average percentage number of condensed nuclei present in 10 different fields, with bars
indicating S.D.
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corroborate the regulatory role of the T95 site in priming
T91/T93 phosphorylation by JNK. Furthermore, the finding
that c-JunA95 is capable to induce neurite outgrowth in
naı¨ve PC12 cells suggests that lack of T91/T93/T95 phospho-
rylation may not interferes with regenerative functions of
c-Jun. However, whether such a functional role of c-Jun
multisite phosphorylation is a general principle, or applies
to specific neuron populations, needs to be explored in
future studies.
A further question addressed by our study is the mechanism
through which lithium blocks c-Jun pro-apoptotic function
without inhibiting JNK activity. The specific effect of lithium on
T91/T93 phosphorylation, together with the evidence that the
c-JunD95 mutant resumes GCG apoptosis in presence of
Figure 5 Phosphorylation of amino-acid residues within c-Jun N-terminal domain. (a) Western blot analysis of HEK-293 cells transfected with DNA constructs expressing
either HA-tagged c-Jun-wt or Ha-tagged c-JunA95, as indicated. After transfection, cells were treated either without or with Anisomycin (100 ng/ml) for indicated time-periods.
c-Jun N-terminal phosphorylation was determined by using the indicated antibodies. (b) Lysates from anisomycin-treated c-Jun-wt-transfected HEK-T cells were
immunoprecipited using the c-total c-Jun antibody, then aliquots from c-Jun immunocomplexes were analyzed by western blot using either c-Jun total antibodies (left panel) or
c-Jun-p91/93 antibodies (right panel). (c) MALDI MS/MS spectra of the [MþH]þ from segments 82–97 carrying three phosphate groups at T91, T93 and T95. (d) MALDI
MS/MS spectra of the [MþNa]þ from segments 62–70 carrying one phosphate group at S63. The a, b and y ions are labeled in each spectrum, as well as b or y ions
corresponding to the neutral loss of phosphoric acid ( 98)
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lithium, is consistent with a model whereby lithium blocks
c-Jun pro-apoptotic activity by targeting the priming T95
phosphorylation event for T91/T93 phosphorylation. In such a
scenario, the priming event for T91/T93 phosphorylation
acquires a crucial role in determining the output of c-Jun
biological activity in response to JNK activation. Mass
spectrometry analysis confirmed that c-Jun is multi-
phosphorylated in vivo at T91/T93/T95, hence validating
that T95 phosphorylation is the priming event for T91/T93
phosphorylation.
Whether lithium controls T91/T93 phosphorylation by
inhibiting a T95-specific kinase or by inducing a phosphatase
remains to be elucidated. However, we show that recombi-
nant JNK-1 fully phosphorylates c-Jun in vitro at the T91/T93
sites in a T95-dependent manner. These results suggest that
JNK sequentially phosphorylates c-Jun at T95-T93-T91 in
response to TK-deprivation, whereas lithium may induce a
T95-specific phosphatase. Although the T95 site does not
contain the minimal S/TP sequence for MAP kinases, it has
been previously shown that both JNK-2 and JNK-1 can
phosphorylate a similar site in histone H2AX.42,43 Future
experiments will elucidate whether in vivo T95 is phosphory-
lated by JNKs or by a lithium-sensitive kinase. Alternatively,
lithium might inhibit T95 phosphorylation by affecting nuclear
translocation of JNKs, hence limiting the local concentration of
active JNKs necessary to phosphorylate the non-canonical
T95 site. Accordingly, inhibition of JNK-2-3 nuclear transloca-
tion was described to protect from apoptosis in sympathetic
neurons and CGCs44,45
Our results provide the first evidence that apoptotic and
survival cues give rises to different site-specific configurations
of c-Jun N-terminal multiphosphorylation, each having a
different functional output in neuronal cells. Furthermore,
our study suggests that inhibition of T91/T93/T95 phosphory-
lation represents a pharmacological tool to selectively target
c-Jun-dependent degenerative pathways in the nervous
system.
Materials and Methods
Animals. All used mouse lines were housed in the central animal facilities of
the University of Wuerzburg. The animal care and ethic committees of our
institutions approved all described procedures and experiments. C57Bl/6 mice
were used for generation of CGCs cultures. Mice carrying a floxed c-Jun allele
(c-Jun fl)46 were kindly provided by Dr. Axel Behrens from Cancer Research UK.
c-Junfl/fl were crossed with mice expressing Cre-recombinase beneath the control
of Nestin promoter47 and crossed again to generate c-Jun fl\fl-nestin-Creþ mice
(c-Jun Dn), in which both c-Jun alleles are inactivated in cells derived from
embryonic neuroepithelium, resulting in CNS-specific inactivation of c-Jun fl, as
previously described.34
Lentiviral production. DNA vectors expressing HA-tagged human c-Jun
proteins8 were used as templates to amplify c-Jun coding regions that were
subsequently cloned into the FUGW vector48 through the BamHI–NotI. The
following primers were used for c-Jun sequence amplification: forward
50-GGATCCATGACTGCAAGATGG-30 and reverse 50-GCGGCCGCTTATCATCT
AGAC3-30. Lentiviral particles were produced as previously described49 (Bender,
FL). HEK 293T cells were transfected with packaging vector pCMVDR8.9 s,
generation envelope vector pVSVG and expression plasmids FUGW-c-Jun-wt
HA-IRES-eGFP or FUGW-c-Jun A95 HA-IRES-eGFP or FUGW-c-Jun D95
HA-IRES-eGFP using Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany).
Supernatants were collected and concentrated by ultracentrifugation. Lentiviruses
were aliquoted and stored at  80 1C until use.
Primary cultures of cerebellar granular cells. CGC cultures were
generated from either C57Bl/6 P7 mice as previously described.29 Briefly, mice
were deeply anesthetized and injected with saline solution to remove the blood.
After the removal of meninges and choroid plexus, cerebella were trypsinized with
BME media containing 1% trypsin and DNase I (2 mg/ml) for 15 min at 37 1C and
Table 1 Phosphopeptides identified by MALDI MS/MS
Sequencea Mr foundb Mr calcb
80–97 IIQSSNGHITTpTPpTPpTQF 2182.90 2182.89
82–97 QSSNGHITTpTPpTPpTQF 1956.73 1956.72
89–98 TTpTPpTPpTQF 1233.40 1232.39
83–95 SSNGHITTpTPpTPT 1473.58 1473.57
87–98 HITTpTPTPTQFL 1436.69 1436.68
87–96 HITTpTPTPTQ 1256.50 1256.50
82–97 QSSNGHITTpTPTPTQF 1796.80 1976.79
81–96 IQSSNGHITTpTPTPTQpyr 1745.79 1745.77
54–60 RAKNSDL 803.44 803.44
61–68 LTpSPDVGL 881.41 881.40
62–70 TpSPDVGLLKc 1144.57 1144.56
56–69 KNSDLLTpSPDVGLLc 1589.73 1589.73
aAmino-acid sequence of phosphorylated peptides identified from peptic
digests on the basis of their CID spectrum. pS denotes phosphoserine and
pT denotes phosphothreonine.
bAll mass values are listed as monoisotopic mass.
cDenotes [M-Na]þadduct
Figure 6 JNK-1 phosphorylates in vitro c-Jun at T91/93 in a T95-dependent
manner. (a) NSC-34 cells were transfected with plasmids expressing either c-Jun-
wt-HA or c-JunA95-HA-tagged proteins (as indicated) and levels of c-Jun site-specific
phosphorylation were analyzed by western blot of total extracts by using the indicated
antibodies. (b) Either c-Jun-wt-HA or c-JunA95-HA-tagged proteins were immunopre-
cipitated by using HA antibodies, then c-Jun-HA immunocomplexes were used as
substrates for in vitro phosphorylation assays by using recombinant JNK-1, either alone
or in combination with recombinant GSK3b as indicated. Products of in vitro
phosphorylation reactions were analyzed by western blot using c-Jun-phospho-specific
antibodies for either p-T91/T93, p-S63 or p-239. Total amounts of c-Jun proteins were
determined by using the c-Jun total antibody. (c) In vitro phosphorylation assay of
recombinant FL-c-Jun protein (Ezio Life Sciences) incubated with recombinant JNK-1
as indicated. Reactions were analyzed by western blot, using either c-Jun-p91/93 or
c-Jun-p-S63 phospho-specific antibodies as indicated. Total amounts of c-Jun proteins
were determined by using the c-Jun total antibody
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then triturated in HBSS containing 10 U/ml DNAse I (Roche Diagnostics,
Mannheim, Germany). Cells were centrifuged at 2000 r.p.m. for 7 min and
resuspended in BME (Sigma, Mannheim, Germany) containing 4 mM glutamine,
10% fetal bovine serum, 100 U/ml Penicillin/streptomycin and 25 mM KCl (Sigma-
Aldrich, Hamburg, Germany). After counting, cells were plated on precoated Poly-
DL-ornithine hydrobromide (PORN-Sigma) glass coverslips (3.5 106) or six-well
multiwell plates (5 106 density). Cultures were maintained at 37 1C, 5% CO2,
and media were changed every 2 days. After 24 h in culture treat the cells with
Ara-C for 1day (Cytosine-1-b-D-arabinofuranoside) to remove proliferating and
non neuronal cells. All experiments were performed 6 days after plating (DIV6).
For serum potassium withdrawal experiments cells were treated with either 5 mM
KCl (LK) or with 25 mM KCl (HK) for 4 h to check phosphorylation levels on
western blot or treat for 18 h for apoptotic assays.
Cell death and survival assay. Cell death of CGCs was assessed by
examining nuclear morphology following DAPI (40,60-diamidino-2-phenylindole
hydrochloride) staining as previously described.50,51 Briefly, DAPI stain (0.5mg/ml)
was added directly to PBS or to secondary antibody and incubated for 20 min at
room temperature. Cells were visualized by fluorescence microscopy (SP2 Leica
fluorescent microscope, Wetzlar, Germany). A minimum of 1000 cells were
analyzed per each treatment. To confirm that condensed nuclei indeed denotes
apoptotic cell, we costained the DAPI with TUNEL staining (In Situ Cell Death
Detection Kit- TMR red-Roche, Mannheim, Germany) according to manufacturer’s
protocol. It is worth noting that in our experimental settings, 100% of TUNEL-
positive cells were stained as condensed nuclei by DAPI, indicating that this is a
valuable assay to measure cell death (Supplementary Figure S1).
PC12 cell culture and transfection. PC12 cell line was cultured on poly-
D-lysine coated dishes in media containing DMEM (Invitrogen) supplemented with
10% horse serum, 5% FCS, 2 mM glutamine and penicillin/streptomycin. Cells
were grown at 37 1C in 5% CO2. For neurite outgrowth, cells were plated at a
density of 1 106 cells per 9 cm dish. Once cells were at 60–70%, confluent PC12
cells were treated with 50 ng/ml of NGF and maintained for 3 days.
PC12 transfections with DNA constructs expressing c-Jun proteins were
performed by using Lipofectamine 2000 reagent (Invitrogen) following the
manufacturer’s instructions. After transfections, cells were cultured in absence of
NGF for 72 h, then were fixed and processed for immunofluorescensce analysis.
Immunocytochemistry. DIV6 cerebellar granule cultures and PC12 cells
were permeabilized with a blocking solution containing 0.3% TritonX-100,
10% Goat serum, 0.1% BSA in TBS for 2 h at room temperature. Then, cells
were incubated overnight at 4 1C with the following primary antibodies: anti-rabbit
c-Jun (Cell Signaling, NEB, Germany, 1 : 200), anti-rabbit phospho-c-Jun-Ser63
(Cell Signaling 1 : 200), anti-rabbit phospho-c-Jun-Thr91 (Cell Signaling 1 : 200),
anti-rabbit phospho-c-Jun-Thr93 (Cell Signaling 1 : 200); or Anti-mouse HA-tag
(Biovision, Hannover, Germany), anti anti-mouse NFL (eBioscience, Frankfurt,
Germany). After removing primary antibodies, cells were washed three times
(10 min each) with TBS and then incubated in permeabilization solution with Alexa-
Fluor-conjugated secondary antibodies for 2 h at room temperature. Cells were
then treated with DAPI for 10 min to stain the nuclei (Sigma-Aldrich 1 : 8000).
Finally, cells were washed three times with TBS for 10 min and one time with PBS
and mounted by using Mowiol (Sigma-Aldrich). Pictures were taken with the SP2
confocal microscope from Leica. Configurations of c-Jun N-terminal phosphoryla-
tion were analyzed by immunocytochemistry 4 h after treatments by using site-
specific c-Jun antibodies recognizing c-Jun when phosphorylated at either S63 or
at T91/T93.
Western blot analysis. Total lysates were prepared from cerebellar primary
cultures by using RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25%
Na-deoxycholate, 150 mM NaCl and 1 mM EDTA and Protease inhibitor) and
leave it on ice for 10 min then centrifuge at 1300 r.p.m. for 30 min. Take
supernatant add1XLaemmli buffer (100 mM Tris-HCl, pH 5 6.8, 2% w/v sodium
dodecyl sulfate (SDS), 20% v/v glycerol, 4% v/v b-mercaptoethanol) and cook for
5 min at 99 1C. Proteins were electrophoresed under reducing condition on 10%
polyacrylamide gel and transferred onto Hybond C nitrocellulose membrane
(Amersham). The membranes were first incubated overnight at 4 1C with a rabbit
anti-c-Jun (Cell Signaling 1 : 1000), or anti-rabbit phospho-c-Jun-Ser63
(Cell Signaling 1 : 1000), or a mixture of anti-rabbit phospho-c-Jun-Thr91 and
anti-rabbit phospho-c-Jun-Thr93 (Cell Signaling 1 : 1000) and MCM7 (Santa Cruz
1 : 2000). Blots were then incubated with peroxidase-linked anti-rabbit (1 : 6000;
Pierce) or anti-mouse (1 : 6000; Chemicon) IgG conjugates for 1 h at room
temperature. Signals were detected with the ECL system (Amersham
Biosciences).
Luciferase assay. For luciferase assays, CGCs were plated into 24-well
plates with 500ml of regular growth medium/well and at DIV5 were transfected
using calcium phosphate method as previously described.33 In brief, transfection
solutions contained 87.6ml of HBS Hepes-buffered saline and 4.4ml of 2.5 M
calcium chloride with 1.0mg of either c-Jun-Wt or c-Jun-A95, 250 ng of Jun2 Luc
and 20 ng of Renilla plasmids. Thirty-five microliters of transfection solutions was
added to a total of 500ml of HBSS and added to cells. Precipitation was allowed
for 50 min. Then cells were washed with HBSS medium twice and incubated with
condition medium. Luciferase activity was then measured using the Dual
Luciferase Kit (Promega, Mannheim, Germany) according to the manufacturer’s
recommendations. Firefly luciferase activity was normalized to the internal
transfection control provided by the Renilla luciferase activity. The normalized
relative light unit values obtained from cells transfected with empty vectors and
cultured at 25 mM K were set as onefold induction.
Immunoprecipitation. HEK 293T or NSC-34 cells were plated at density of
5 million (5 106) cells per 10 cm dish and 18 h later were transfected by using
Lipofectamine 2000 reagent (Invitrogen) with FUGW-c-Jun constructs. After
48 hours total proteins were extracted with RIPA buffer as previously described.8
Primary antibodies, either anti-rabbit c-Jun antibodies (Cell Signalling 9165) or
sepharose-conjugated mouse HA antibodies (Covance clone 16B12 monoclonal),
were added to total cell extracts and incubated overnight at 4 1C. Immuno-
precipitated proteins complexes were collected by using Protein A-agarose beads
(Roche) previously washed with PBS and equilibrated with RIPA buffer. After 1 h
incubation, pellets were collected by centrifugation at 1000 g, and beads were
washed three times with RIPA buffer. For in vitro phosphorylation assays,
immunocomplexes were equilibrated in kinase buffer.
In vitro kinase assay. Kinase assays were performed by using either
c-Jun-Ha immunocomplexes or recombinant FL-c-Jun protein (200 ng, Enzo Life
Sciences, Lausen, Switzerland) and either active recombinant JNK-1 (Millipore
(Zug, Switzerland) 20 ng/20ml reaction) or GSK3b (Biovision, 5 ng/20ml). Assays
were performed in a total volume of 20ml, containing 1x kinase buffer (50 mM
HEPES (pH 7.4), 1 mM MgCl2, 20 mM beta-glycerophosphate, 1 mM Na3VO4,
0.2 mM dithiothreitol (DTT), 1mM pepstatin A, 1 mM PMSF, protease inhibitor and
10 mM ATP). Reactions were stopped by the addition of SDS sample buffer
(100 mM Tris (pH 6.8), 2% SDS, 10% glycerol, 5% beta-mercaptoethanol and
0.25% bromophenol blue). Phosphorylation of c-Jun proteins was analyzed by
western blot analysis using either p-S63 or the p-T91/93 phospho-specific c-Jun
antibodies described above.
Mass spectrometry and protein identification
Materials: Solvents (CH3OH, CH3CN and H2O, HPLC grade), reagent
(CH3COONa, KCl, EDTA, pure g99.5%), trifluoroacetic acid (HPLC grade, pure
g99.0%), pepsin and 3,5-dimethoxy-4-hydroxycinnamic acid (pure g99.0%),
R-cyano-4-hydroxy-trans-cynnamic acid (R-CHCA, pure g99.0%) were purchased
from Sigma-Aldrich Fluka (Milano, Italy). HAP (BIO-GEL HTP) was purchased
from Bio-Rad (Milan, Italy).
In-gel digestion: For MS analysis, the spots of interest were excised from 1-DE
gels and analyzed by matrix-assisted laser desorption ionization/time-of-flight
(MALDI-TOF/TOF). After SDS-PAGE, discrete band was excised from the blue-
coomassie-stained gel. The in-gel digestion with proteinase K was carried out as
previously described.52 To obtain extensively cleaved protein, the digestion was
performed at 37 1C for 18 h twice. Peptides were subsequently extracted twice
with 100ml of 50% ACN/2% trifluoroacetic acid (TFA); the extracted solutions were
then combined and dried with the Speed Vac concentrator. The peptide pellets
were then resuspended in 100ml of 40% ACN/0.1%. For MS MS/MS experiments,
the peptic peptide mixture (10 ml) was desalted and concentrated in ZipTipC18
devices (Millipore).
Optimized enrichment procedure for phosphopeptides: HAP was
performed in order to obtain an enriched fraction of phosphopeptides. HAP spin
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down column was manufactured in our laboratory using BIO-GEL HTTP/sample
ratio 2 : 1(mg/ml). Ten milliliters of the reconstituted peptides mixture was dried in a
vacuum centrifuge and resuspended in 100ml of loading buffer (TRIS 10 mM,
EDTA, 1 mM pH 7). The peptides solution was loaded onto 20 mg of HAP that was
previously packed with loading buffer. The HAP-bound peptides were incubated at
room temperature for 15 min twice. After, the column was washed with loading
buffer to remove unretained peptides. The phosphopeptides were eluted with
100ml of elution buffer (KCl 100 mM, TRIS 20 mM, EDTA 2 mM, pH 8). All fraction
were dried in a vacuum centrifuge, resuspended in 100ml of 40% ACN/0.1%,
desalted in reverse-phase Zip Tips.
Protein identification by MALDI MS and MS/MS analysis: Ten
microliters of the all fractions was desalted using ZipTipC18 prior MS analysis.
Peptides were eluted directly into 5ml of matrix solution (5 mg/ml R-cyano-4-
hydroxycinnamic acid (CHCA) in 50% ACN, 0.1% v/v TFA) in order to maximize
concentration of peptides in sample spot. Mass spectrometry analyses were
performed using an 5800 MALDI-TOF-TOF Analyzer (AB SCIEX, Darmstadt,
Germany) equipped with a neodymium: yttrium-aluminum-garnet laser (laser
wavelength was 349 nm), in reflection positive-ion mode with a mass accuracy of
5 p.p.m. At least 4000 laser shots were typically accumulated with a laser pulse
rate of 400 Hz in the MS mode, whereas in the MS/MS mode spectra up to 5000
laser shots were acquired and averaged with a pulse rate of 1000 Hz. MS/MS
experiments were performed at a collision energy of 1 kV, ambient air was used as
collision gas with medium pressure of 10-6 Torr. After acquisition, spectra were
handled using Data Explorer version 4.0. The mass data were processed to assign
candidate peptides in the SwissProt database using the MASCOT search
program. Peptide Mass Fingerprinting (PMF) interrogation identified (P05412),
TRANSCRIPTION FACTOR AP-1 (PROTO-ONCOGENE C-JUN) (P39) (G0S7)
using 34m/z values, sequence coverage: 62%, (score 91). A mass tolerance of
50 p.p.m. was used and up to four missed pepsin cleavage was allowed.
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